HIV care records review in South Africa
Part of Infections clinical trials.
This study gathers and reviews existing records from people receiving care for HIV in South Africa. It aims to better understand how HIV treatment is working in real-world settings and for different types of risk groups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 15 years old
- Be in HIV care during the time the study collects data
- Be able to be placed in one of the study’s HIV transmission risk groups
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses health records to learn how people in Zambia access HIV care and treatments. It may help improve future HIV support and treatment planning.
This study gathers information from people receiving HIV care in Malawi to better understand and improve HIV treatment. You may be included if you are an adult or older and you are currently accessing HIV care during the study’s time period.
This trial looks at how care is being provided to adults with HIV who may be on treatment or not, and regardless of immune strength. It may help improve future care plans by identifying what works best in real-world settings.
This study tests whether getting HIV care through a community program is as helpful as going to a clinic for people who just found out they have HIV. It looks at how well they stay in care and take their medicine.
This trial helps hospitals find undiagnosed HIV by improving testing and care. It supports healthcare teams to identify HIV in people with certain conditions and ensures those diagnosed get connected to treatment.
This study tests how well researchers can track HIV-related health and immune changes over time by collecting blood and other samples. It may help you and your care team by creating detailed monitoring, even if your HIV diagnosis is new or still being evaluated.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.